Table 4.
Comparison of biochemical parameters
| Biochemical parameters | Clinical parameters | |||||
|---|---|---|---|---|---|---|
| PPD | CAL | GI | PI | BOP | ||
| Eotaxin | r | –0.290* | –0.257* | –0.272* | –0.195 | –0.247* |
| p | 0.013 | 0.028 | 0.020 | 0.098 | 0.035 | |
| FGF | r | –0.087 | –0.053 | –0.001 | 0.010 | 0.020 |
| p | 0.465 | 0.656 | 0.992 | 0.935 | 0.864 | |
| G-CSF | r | 0.004 | –0.010 | –0.012 | –0.019 | –0.014 |
| p | 0.975 | 0.936 | 0.923 | 0.871 | 0.907 | |
| GM-CSF | r | –0.195 | –0.287* | –0.325** | –0.324** | –0.339** |
| p | 0.098 | 0.014 | 0.005 | 0.005 | 0.003 | |
| IFN-γ | r | –0.069 | 0.027 | 0.012 | –0.041 | 0.020 |
| p | 0.563 | 0.819 | 0.918 | 0.733 | 0.864 | |
| IL-10 | r | –0.127 | –0.098 | –0.092 | –0.140 | –0.099 |
| p | 0.284 | 0.409 | 0.436 | 0.238 | 0.407 | |
| IL-12 | r | –0.158 | –0.132 | –0.137 | –0.172 | –0.119 |
| p | 0.181 | 0.267 | 0.249 | 0.145 | 0.315 | |
| IL-13 | r | –0.201 | –0.237* | –0.167 | –0.165 | –0.162 |
| p | 0.088 | 0.044 | 0.158 | 0.163 | 0.171 | |
| IL-15 | r | –0.403** | –0.422** | –0.341** | –0.429** | –0.357** |
| p | 0.000 | 0.000 | 0.003 | 0.000 | 0.002 | |
| IL-17 | r | –0.133 | 0.010 | 0.056 | 0.041 | 0.032 |
| p | 0.260 | 0.934 | 0.641 | 0.730 | 0.785 | |
| IL-1β | r | 0.259* | 0.287* | 0.287* | 0.207 | 0.298* |
| p | 0.027 | 0.014 | 0.014 | 0.078 | 0.011 | |
| IL-1ra | r | –0.190 | –0.166 | –0.167 | –0.148 | –0.158 |
| p | 0.108 | 0.161 | 0.159 | 0.212 | 0.182 | |
| IL-2 | r | –0.375** | –0.334** | –0.293* | –0.264* | –0.300** |
| p | 0.001 | 0.004 | 0.012 | 0.024 | 0.010 | |
| IL-4 | r | –0.080 | 0.027 | 0.004 | 0.013 | 0.027 |
| p | 0.503 | 0.822 | 0.976 | 0.911 | 0.819 | |
| IL-5 | r | –0.043 | –0.059 | –0.069 | –0.073 | –0.089 |
| p | 0.720 | 0.622 | 0.559 | 0.540 | 0.452 | |
| IL-6 | r | 0.001 | 0.076 | –0.045 | 0.084 | –0.027 |
| p | 0.996 | 0.520 | 0.708 | 0.482 | 0.821 | |
| IL-7 | r | –0.107 | –0.022 | –0.076 | –0.056 | –0.070 |
| p | 0.366 | 0.856 | 0.522 | 0.636 | 0.557 | |
| IL-8 | r | –0.177 | –0.166 | –0.217 | –0.222 | –0.235* |
| p | 0.134 | 0.161 | 0.065 | 0.059 | 0.045 | |
| IL-9 | r | –0.220 | –0.065 | –0.038 | 0.032 | –0.074 |
| p | 0.062 | 0.583 | 0.747 | 0.787 | 0.531 | |
| IP-10 | r | 0.485** | 0.348** | 0.351** | 0.337** | 0.375** |
| p | 0.000 | 0.003 | 0.002 | 0.004 | 0.001 | |
| MCP-1 | r | –0.052 | 0.024 | 0.000 | 0.040 | 0.013 |
| p | 0.660 | 0.838 | 1.000 | 0.739 | 0.912 | |
| MIP-1α | r | –0.061 | 0.107 | 0.072 | 0.045 | 0.081 |
| p | 0.609 | 0.367 | 0.547 | 0.708 | 0.498 | |
| MIP-1β | r | –0.282* | –0.277* | –0.285* | –0.280* | –0.286* |
| p | 0.016 | 0.017 | 0.015 | 0.016 | 0.014 | |
| PDGF-BB | r | –0.202 | –0.166 | –0.188 | –0.141 | –0.201 |
| p | 0.087 | 0.160 | 0.110 | 0.233 | 0.088 | |
| RANTES | r | –.012 | 0.043 | 0.058 | –0.047 | 0.010 |
| p | 0.919 | 0.717 | 0.628 | 0.695 | 0.930 | |
| TNF-α | r | –0.060 | –0.021 | 0.046 | 0.044 | 0.032 |
| p | 0.613 | 0.857 | 0.697 | 0.715 | 0.786 | |
| VEGF | r | –0.035 | 0.101 | 0.091 | 0.015 | 0.080 |
| p | 0.769 | 0.395 | 0.444 | 0.902 | 0.499 | |